СПОСОБ ЛЕЧЕНИЯ НАЧАЛЬНОЙ СТАДИИ ВОЗРАСТНОЙ КАТАРАКТЫ

摘要

FIELD: medicine. ^ SUBSTANCE: invention relates to ophthalmology. Conjuctisan A is instilled into conjuctival cavity. Additionally it is introduced under conjunctiva during 4-6 weeks in dose of 0.25 ml two times a week. Parallel with instillation of conjunctisan A patient takes in 1 capsule of 250 ml mildronate 2 times a day during 30 days. ^ EFFECT: ensuring activation of metabolism and microcirculation in eye lens at initial stages of age-specific cataract. ^ 2 ex